• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氧氟沙星与其他抗菌剂的联合使用。 不过你提供的原文“Combination of ofloxacin and other antimicrobial agents.”中多了一个“of”,正确的应该是“Combination of ofloxacin and other antimicrobial agents” 。

Combination of ofloxacin and other antimicrobial agents.

作者信息

Chin N X, Neu H C

机构信息

Department of Medicine, College of Physicians & Surgeons, Columbia University, New York, New York 10032.

出版信息

J Chemother. 1990 Dec;2(6):343-7. doi: 10.1080/1120009x.1990.11739040.

DOI:10.1080/1120009x.1990.11739040
PMID:2093103
Abstract

We evaluated the combination of ofloxacin with piperacillin, gentamicin, vancomycin, rifampin, clindamycin, and metronidazole by the checkerboard agar dilution method against 165 isolates which included Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Serratia marcescens, Pseudomonas aeruginosa, Providencia stuartii, Acinetobacter, Staphylococcus aureus, Bacteroides fragilis, and Citrobacter perfringens. Synergy of piperacillin-ofloxacin was demonstrated for 50% and 40% respectively of E. cloacae and P. aeruginosa. Some ofloxacin and piperacillin-resistant isolates were susceptible with the combination. Ofloxacin-gentamicin was indifferent for aerobic gram-negative species. Ofloxacin and vancomycin or gentamicin was indifferent for S. aureus and E. faecalis, but rifampin-ofloxacin showed addition. Combination of ofloxacin and metronidazole or clindamycin or erythromycin was indifferent for aerobic and anaerobic species. Ofloxacin could be combined with piperacillin with benefit against P. aeruginosa, but combination with aminoglycosides is not of benefit.

摘要

我们采用棋盘琼脂稀释法,评估了氧氟沙星与哌拉西林、庆大霉素、万古霉素、利福平、克林霉素及甲硝唑联合应用对165株分离菌的抗菌活性,这些分离菌包括大肠杆菌、肺炎克雷伯菌、阴沟肠杆菌、粘质沙雷菌、铜绿假单胞菌、斯氏普罗威登斯菌、不动杆菌、金黄色葡萄球菌、脆弱拟杆菌及产气荚膜梭菌。哌拉西林-氧氟沙星联合用药对50%的阴沟肠杆菌及40%的铜绿假单胞菌显示协同作用。一些对氧氟沙星和哌拉西林耐药的菌株对联合用药敏感。氧氟沙星-庆大霉素对需氧革兰阴性菌无协同作用。氧氟沙星与万古霉素或庆大霉素对金黄色葡萄球菌和粪肠球菌无协同作用,但利福平-氧氟沙星显示相加作用。氧氟沙星与甲硝唑、克林霉素或红霉素联合应用对需氧菌和厌氧菌无协同作用。氧氟沙星与哌拉西林联合应用对铜绿假单胞菌有益,但与氨基糖苷类联合应用无益处。

相似文献

1
Combination of ofloxacin and other antimicrobial agents.氧氟沙星与其他抗菌剂的联合使用。 不过你提供的原文“Combination of ofloxacin and other antimicrobial agents.”中多了一个“of”,正确的应该是“Combination of ofloxacin and other antimicrobial agents” 。
J Chemother. 1990 Dec;2(6):343-7. doi: 10.1080/1120009x.1990.11739040.
2
In vitro activity and beta-lactamase stability of a new penem, CGP 31608.新型青霉烯类药物CGP 31608的体外活性及β-内酰胺酶稳定性
Antimicrob Agents Chemother. 1987 Apr;31(4):558-69. doi: 10.1128/AAC.31.4.558.
3
Synergistic interaction between ofloxacin and cefotaxime against common clinical pathogens.
Infection. 1995 May-Jun;23(3):154-61. doi: 10.1007/BF01793856.
4
[Susceptibilities of clinical isolates to antibacterial agents. A study mainly focused on ofloxacin (the second report). Reported by the Research Group for Testing ofloxacin Susceptibility on Clinical Isolates].临床分离株对抗菌药物的敏感性。一项主要聚焦于氧氟沙星的研究(第二篇报告)。临床分离株氧氟沙星敏感性检测研究组报告
Jpn J Antibiot. 1989 May;42(5):1125-65.
5
Comparative in vitro activity of gemifloxacin, ciprofloxacin, levofloxacin and ofloxacin in a North American surveillance study.北美一项监测研究中吉米沙星、环丙沙星、左氧氟沙星和氧氟沙星的体外活性比较
Diagn Microbiol Infect Dis. 2001 May-Jun;40(1-2):51-7. doi: 10.1016/s0732-8893(01)00241-3.
6
In vitro interaction between ofloxacin and cefotaxime against gram-positive and gram-negative bacteria involved in serious infections.氧氟沙星与头孢噻肟对严重感染中涉及的革兰氏阳性菌和革兰氏阴性菌的体外相互作用。
Chemotherapy. 1998 Mar-Apr;44(2):94-8. doi: 10.1159/000007098.
7
In vitro pharmacodynamics of piperacillin, piperacillin-tazobactam, and ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa.哌拉西林、哌拉西林-他唑巴坦和环丙沙星单独及联合应用对金黄色葡萄球菌、肺炎克雷伯菌、阴沟肠杆菌和铜绿假单胞菌的体外药效学。
Antimicrob Agents Chemother. 1995 Aug;39(8):1711-6. doi: 10.1128/AAC.39.8.1711.
8
In-vitro activity of trovafloxacin against sensitive and resistant aerobic bacteria using the standard microdilution broth method and Etest.采用标准微量稀释肉汤法和Etest法测定曲伐沙星对需氧敏感菌和耐药菌的体外活性。
J Antimicrob Chemother. 1997 Jun;39 Suppl B:35-42. doi: 10.1093/jac/39.suppl_2.35.
9
Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampin used singly and in combination against Legionella pneumophila.左氧氟沙星、氧氟沙星、红霉素和利福平单独及联合使用对嗜肺军团菌的抑制和杀菌活性。
Antimicrob Agents Chemother. 1995 Aug;39(8):1661-6. doi: 10.1128/AAC.39.8.1661.
10
Determination of activities of levofloxacin, alone and combined with gentamicin, ceftazidime, cefpirome, and meropenem, against 124 strains of Pseudomonas aeruginosa by checkerboard and time-kill methodology.采用棋盘法和时间杀菌法测定左氧氟沙星单独及与庆大霉素、头孢他啶、头孢匹罗和美罗培南联合使用时对124株铜绿假单胞菌的活性。
Antimicrob Agents Chemother. 1998 Apr;42(4):953-5. doi: 10.1128/AAC.42.4.953.

引用本文的文献

1
Synergy of levofloxacin (L-ofloxacin) and oxacillin against quinolone-resistant Staphylococcus aureus, measured by the time-kill method.采用时间杀菌法测定左氧氟沙星(L-氧氟沙星)与苯唑西林对耐喹诺酮金黄色葡萄球菌的协同作用。
Antimicrob Agents Chemother. 1993 Feb;37(2):339-41. doi: 10.1128/AAC.37.2.339.
2
Pharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection model.左氧氟沙星、氧氟沙星和环丙沙星单独及与利福平联合应用,在体外感染模型中对甲氧西林敏感和耐药金黄色葡萄球菌的药效学研究。
Antimicrob Agents Chemother. 1994 Dec;38(12):2702-9. doi: 10.1128/AAC.38.12.2702.
3
Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.
氧氟沙星。对其抗菌活性、药理学及治疗用途的重新评估。
Drugs. 1991 Nov;42(5):825-76. doi: 10.2165/00003495-199142050-00008.